Lei-Jie Dai
- Topics
- HER2/EGFR in Cancer Research (4 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)Advanced Breast Cancer Therapies (2 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- ChinaJapanUnited Kingdom
In The Last Decade
Lei-Jie Dai
8 papers receiving 378 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 182
- Molecular Biology 149
- Immunology 132
- Pulmonary and Respiratory Medicine 97
- Cancer Research 93
Countries citing papers authored by Lei-Jie Dai
This map shows the geographic impact of Lei-Jie Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei-Jie Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei-Jie Dai more than expected).
Fields of papers citing papers by Lei-Jie Dai
This network shows the impact of papers produced by Lei-Jie Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei-Jie Dai. The network helps show where Lei-Jie Dai may publish in the future.
Co-authorship network of co-authors of Lei-Jie Dai
This figure shows the co-authorship network connecting the top 25 collaborators of Lei-Jie Dai. A scholar is included among the top collaborators of Lei-Jie Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei-Jie Dai. Lei-Jie Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancerbreakdown → | 18 |
| 2 | 18 | |
| 3 | 37 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic responsebreakdown → | 287 |
| 8 | 13 | |
| 9 | 2 |
About Lei-Jie Dai
Lei-Jie Dai is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 378 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (182 citations), Immunology (132 citations) and Cancer Research (93 citations). Lei-Jie Dai has collaborated with scholars based in China, Japan and United Kingdom. Frequent co-authors include Yi‐Zhou Jiang, Song‐Yang Wu, Yi Xiao, Tong‐Ming Fu, Ding Ma, Zhi-Ming Shao, Zhi‐Ming Shao, Wentao Yang, Xi Jin and Han Wang. Their work appears in journals such as Nature Communications, Cancer Cell and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.